Overview
Meeting:
Day One: March 6 – 10:00AM-4:15PM
Day Two: March 7 – 10:00AM-4:30PM
Day Three: March 8 - 10:00AM-4:30PM
*The primary language is English, however simultaneous interpretation in Spanish will be available during this webinar.
DIA is thrilled to announce our 2023 Latin America Annual Meeting (formerly known as Latin America Regulatory Conference) that will include opportunities for networking and knowledge sharing with key stakeholders influencing the advancement and implementation of initiatives in Latin America and the Caribbean. This new meeting expands in scope from our previous meetings discussing topics relating to the Latin America region, and presents the following three tracks: Regulatory, Clinical and Pharmacovigilance. Cross-track sessions provide the opportunity to discuss key connection points across major components of regulatory, clinical and pharmacovigilance initiatives, efforts and collaboration within these functional areas in an organization or company. Join us to discuss multi-regional cooperation, global harmonization, lessons learned, and best practices to stimulate discussion and foster collaboration amongst stakeholders in Latin America and the Caribbean. Join regulators from World Health Organization (WHO), ANVISA, Pan American Health Organization (PAHO), Instituto de Salud Pública de Chile, National Directorate of Medicines, El Salvador, Ministry of Health of Costa Rica, Caribbean Public Health Agency (CARPHA), Health Canada and more.
Registered attendees will receive access to all session recordings for 2 full months post-conference! This allows you to remain flexible with your schedule and not worry if you need to miss a session. Have a conflict with the dates of the conference? Register anyway and you will receive access to the recordings!
Need approval in order to attend? Download and fill out our Justification Letter to demonstrate to your supervisor why this is a must-attend event.
Keynote Address!
March 6 | 10:00-11:00AM
The Modernization of Regulatory Systems – How to Embed New Technology and Innovation to Future-Proof the Regulatory Environment
Samvel Azatyan, MD, PhD, Team Lead, Regulatory Convergence and Networks (RCN/REG), World Health Organization (WHO), Switzerland
Welcome Video in English
*The primary language is English, however simultaneous interpretation in Spanish will be available during this webinar.
Welcome Video in Spanish
*The primary language is English, however simultaneous interpretation in Spanish will be available during this webinar.
Program Committee
-
Fernanda Lessa, MBA, MPH Health Regulatory Systems
Consultant, Switzerland -
Viktoria Magyar, LLM, MSc Doctoral Student, Department of Regulatory and Quality Sciences
USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, United States -
Maria Antonieta Tony Roman, MPharm Head Regulatory Policy Emerging Markets LATAM
Novartis, Mexico -
Leonardo Semprun, PharmD Global Regulatory Policy Lead-LatAm
MSD, Panama -
Urimara Argotti-Rodriguez, MBA Regional Regulatory Policy LATAM Region, Global International Regulatory Policy
Productos Roche S.A. DE C.V., Mexico -
Flavia Firmino Ribeiro, PharmD Director Reg Global CMC
Pfizer, Brazil -
Gislaine Villarta Capeleti Dib, PharmD Patient Safety Manager
PGA Farma, Brazil -
Raphael Elmadjian Pareschi, PharmD, MBA Patient Safety Lead/ Head of Pharmacovigilance Brazil
Roche, Brazil -
Rosana M. Mastellaro, PharmD, RPh Director, Technical Regulatory Affairs and Innovation
Sindusfarma, Brazil -
Bianca Passos, MBA, RPh Country Safety Head - Brazil
Sanofi, Brazil -
Michelle Arguelles Gonzalez, MBA, RPh, PMP Executive Director, Clinical Research
Merck Sharp & Dohme (MSD), Mexico -
Duglas Rodriguez Calderon, MSc Global Head of LATAM Regulatory Policy, Global Regulatory Policy & Intelligence
Roche, United States -
Lorena Larrosa, RPh Regulatory Affairs Manager
Abbvie, Uruguay -
Susan Koepke, MBA Head of Regulatory Affairs LATAM
EMD Serono, Inc., United States -
Representative Invited DIA, United States
-
Ana Pineda Zavaleta, MSc International Regulatory Analyst, LAO, OGPS, OPLIA, OC
FDA, United States
Have an account?